Mirae Asset Global Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,496
| Closed | -$10.7K | – | 1685 |
|
|
2024
Q4 | $10.7K | Sell |
3,496
-295
| -8% | -$903 | ﹤0.01% | 1509 |
|
|
2024
Q3 | $20.3K | Buy |
3,791
+673
| +22% | +$3.61K | ﹤0.01% | 1432 |
|
|
2024
Q2 | $8.04K | Sell |
3,118
-34,500
| -92% | -$89K | ﹤0.01% | 1475 |
|
|
2024
Q1 | $1.11M | Sell |
37,618
-405
| -1% | -$12K | ﹤0.01% | 1477 |
|
|
2023
Q4 | $334K | Buy |
38,023
+126
| +0.3% | +$1.11K | ﹤0.01% | 2155 |
|
|
2023
Q3 | $435K | Buy |
37,897
+166
| +0.4% | +$1.9K | ﹤0.01% | 1952 |
|
|
2023
Q2 | $955K | Buy |
37,731
+689
| +2% | +$17.4K | ﹤0.01% | 1593 |
|
|
2023
Q1 | $1.19M | Sell |
37,042
-40
| -0.1% | -$1.29K | ﹤0.01% | 1448 |
|
|
2022
Q4 | $685K | Buy |
37,082
+5,493
| +17% | +$101K | ﹤0.01% | 1712 |
|
|
2022
Q3 | $853K | Buy |
31,589
+9,964
| +46% | +$269K | ﹤0.01% | 1574 |
|
|
2022
Q2 | $299K | Buy |
+21,625
| New | +$299K | ﹤0.01% | 1990 |
|
|
2017
Q1 | – | Sell |
-15,633
| Closed | -$323K | – | 672 |
|
|
2016
Q4 | $323K | Buy |
+15,633
| New | +$323K | 0.01% | 447 |
|